PFM Health Sciences’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $9.8M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $44.1M | Buy |
|
|||||
|
2023
Q2 | $30.4M | Buy |
|
|||||
|
2023
Q1 | $15.5M | Sell |
|
|||||
|
2022
Q4 | $32.1M | Sell |
|
|||||
|
2022
Q3 | $94.6M | Buy |
|
|||||
|
2022
Q2 | $69.6M | Buy |
|
|||||
|
2022
Q1 | $55.4M | Buy |
|
|||||
|
2021
Q4 | $41.1M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $27.6M | Sell |
|
|||||
|
2020
Q3 | $53.3M | Buy |
|
|||||
|
2020
Q2 | $59.6M | Buy |
|
|||||
|
2020
Q1 | $33.8M | Sell |
|
|||||
|
2019
Q4 | $46.8M | Sell |
|
|||||
|
2019
Q3 | $145M | Buy |
|
|||||
|
2019
Q2 | $178M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $13.9M | Sell |
|
|||||
|
2017
Q1 | $86.3M | Sell |
|
|||||
|
2016
Q4 | $87.6M | Buy |
|
|||||
|
2016
Q3 | $66.9M | Buy |
|
|||||
|
2016
Q2 | $44.4M | Buy |
|